Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas

NCT00996346 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Original PI left institution and sponsor decided to end support.

Conditions

Sarcoma

Interventions

DRUG: Irinotecan&Temsirolimus:Arm1, Level 1
DRUG: Irinotecan&Temsirolimus:Arm 1, Level 2
DRUG: Irinotecan&Temsirolimus:Arm 2, Level 1

Sponsor

New Mexico Cancer Research Alliance

Collaborators

[object Object]